EKSO Ekso Bionics Holdings Inc

Ekso Bionics to Report Second Quarter 2025 Financial Results on July 28 – Conference Call to Follow

Ekso Bionics to Report Second Quarter 2025 Financial Results on July 28 – Conference Call to Follow

SAN RAFAEL, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter of 2025 after the close of trading on Monday, July 28, 2025. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to review the financial results and discuss recent business developments.

To participate in the conference call by telephone, please dial 877-407-6184 (domestic) or 201-389-0877 (international). The call will also be broadcast live and archived on the Company’s website at under “Presentations & Events” in the Investors section.

About Ekso Bionics®

Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Based upon its industry-leading expertise, the Company focuses on improving health and quality of life with advanced robotics designed to enhance, amplify, and restore human function. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: .

Contact:

Stephen Kilmer

Investor Relations

Direct: (646) 274-3580

Email:



EN
21/07/2025

Underlying

EKSOEkso Bionics Holdings Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ekso Bionics Holdings Inc

 PRESS RELEASE
Free
EKSO Ekso Bionics Ho...

Ekso Bionics to Report Second Quarter 2025 Financial Results on July 2...

Ekso Bionics to Report Second Quarter 2025 Financial Results on July 28 – Conference Call to Follow SAN RAFAEL, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter of 2025 after the close of trading on Monday, July 28, 2025. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to review the financial results and discuss recent business developments...

22h / 23m 1 EN
 PRESS RELEASE
Free
EKSO Ekso Bionics Ho...

Virtual eksoUniversity to Support Continuing Education of PTs and PTAs...

Virtual eksoUniversity to Support Continuing Education of PTs and PTAs Across the Country On-demand courses already approved for CEUs in over 30 states SAN RAFAEL, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and industrial use, is pleased to announce the launch of , a new platform providing continuing education courses to physical therapists (“PTs”) and physical therapy assistants (“PTAs”) across the country. Most states require healthcare professionals t...

July 18, 2025 1 EN
 PRESS RELEASE
Free
EKSO Ekso Bionics Ho...

Ekso Bionics’ Acceptance into NVIDIA Connect Program Bears Early Fruit

Ekso Bionics’ Acceptance into NVIDIA Connect Program Bears Early Fruit AI voice agent for user interface being designed to support exoskeleton device operation, motivation, training, and safety First proof-of-concept demonstration comes just over a month after Company into the NVIDIA Connect Program SAN RAFAEL, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it has successfully demonstrated initial proof-of-concept in ...

June 18, 2025 1 EN
 PRESS RELEASE
Free
EKSO Ekso Bionics Ho...

Ekso Bionics Announces New Effective Date of Reverse Stock Split

Ekso Bionics Announces New Effective Date of Reverse Stock Split SAN RAFAEL, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that it has updated the effective date of its reverse stock split of shares of its common stock at a ratio of 1-for-15 to June 2, 2025 at 12:01 a.m., Pacific time, rather than the previously disclosed effective date of May 27, 2025 at 12:01 a.m. Pacific time. The Company’s common stock will open for trading on The Nasdaq Capital Ma...

May 21, 2025 1 EN
 PRESS RELEASE
Free
EKSO Ekso Bionics Ho...

Ekso Bionics Announces Reverse Stock Split

Ekso Bionics Announces Reverse Stock Split SAN RAFAEL, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that it will effect a reverse stock split of shares of its common stock at a ratio of 1-for-15, effective as of May 27, 2025 at 12:01 a.m. Pacific time. The Company’s common stock will open for trading on The Nasdaq Capital Market on May 27, 2025 on a split-adjusted basis under the existing symbol “EKSO”. The Company’s common stock will trade under a ne...

May 19, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch